TRANSDERMAL NITROGLYCERIN PATCH THERAPY REDUCES THE EXTENT OF EXERCISE-INDUCED MYOCARDIAL-ISCHEMIA - RESULTS OF A DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL USING QUANTITATIVE TL-201 TOMOGRAPHY
Jj. Mahmarian et al., TRANSDERMAL NITROGLYCERIN PATCH THERAPY REDUCES THE EXTENT OF EXERCISE-INDUCED MYOCARDIAL-ISCHEMIA - RESULTS OF A DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL USING QUANTITATIVE TL-201 TOMOGRAPHY, Journal of the American College of Cardiology, 24(1), 1994, pp. 25-32
Objectives. This study prospectively evaluated whether trans dermal ni
troglycerin patches could limit the extent of exercise-induced left ve
ntricular ischemia as assessed by quantitative thallium-201 tomography
. Background. Although antianginal medications are effective at reduci
ng chest pain symptoms in patients with coronary artery disease, there
is limited evidence that these agents can also reduce myocardial isch
emia. Methods. This was a randomized, double blind, parallel, placebo-
controlled trial evaluating nitroglycerin patch therapy in patients in
stable condition with angiographic coronary artery disease and no pre
vious myocardial infarction. All patients were weaned from antianginal
agents and had a baseline symptom-limited treadmill test followed by
thallium-201 tomography. Forty patients with perfusion defects involvi
ng greater than or equal to 5% of the left ventricle were randomized t
o receive either intermittent (12 h on/off) active nitroglycerin patch
therapy (0.4 mg/h) or placebo. Exercise tomography was repeated a mea
n (+/-SD) of 6.1 +/- 1.8 days after randomization. Results. Patients r
andomized to receive active patch therapy had a significant reduction
in their total perfusion defect size (-8.9 +/- 11.1%) compared with pl
acebo treated patients (-1.8 +/- 6.1%, p = 0.04), which was most appar
ent in those with the largest (greater than or equal to 20%) baseline
perfusion defects (-11.4 +/- 13.4% vs. 1.0 +/- 3.6%, respectively, p <
0.02). Furthermore, 7 (33%) of 21 patients receiving active therapy h
ad a greater than or equal to 10% decrease in their perfusion defects
compared with only 1 (5%) of 19 patients randomized to receive placebo
(p = 0.002). Nitrate therapy did not significantly reduce heart rate,
blood pressure or double product, indicating benefit through enhancem
ent of coronary blood dow. Conclusions. Short-term, intermittent nitro
glycerin patch therapy significantly reduces myocardial ischemia, part
icularly in patients with large ischemic perfusion defects. Thallium-2
01 tomography can be used to assess sequential changes in the extent o
f exercise-induced left ventricular ischemia.